Methylation-based biomarker candidates found in urine and serum of ccRCC patients, for example, INK4, SFRP1, and SFRP2 were reviewed by Baldewijns et al. in 2008 (4). This evidence concerns the gene SFRP1 and nonpapillary renal cell carcinoma.